Health Care Up Amid Deal Activity -- Health Care Roundup
I'm PortAI, I can summarize articles.
Health-care companies rose amid deal activity. Biomarin Pharmaceutical agreed to buy fellow biotechnology company Amicus Therapeutics for about $4.8 billion. Amicus founder and longtime leader, John Crowley started the company to find a cure for his two children's rare disease. Nine pharmaceutical companies, including Merck and British drug giant GSK, agreed to lower certain U.S. prices for their medicines in a new round of industry pacts with the Trump administration. Write to Rob Curran at rob.curran@dowjones.com (END) Dow Jones Newswires 12-19-25 1732ET
Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments